• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER TREVISIO INTRAVASCULAR DELIVERY SYSTEM; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER TREVISIO INTRAVASCULAR DELIVERY SYSTEM; CATHETER, PERCUTANEOUS Back to Search Results
Catalog Number 9-ATV07F45/80
Medical Device Problem Code Air/Gas in Device (4062)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/23/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2023, a 7f amplatzer trevisio intravascular delivery system (atv) was chosen for a procedure.During the preparation, while rinsing it was noted that the y piece, or hemostasis valve, of the device was screwed on tightly, and air was drawn through the y piece.The delivery system did not make patient contact.A new 8f amplatzer trevisio intravascular delivery system was chosen and the procedure completed successfully.There was no reported patient issue.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2023, a 7f amplatzer trevisio intravascular delivery system (atv) was chosen for a procedure.During the preparation, while rinsing it was noted that the y piece, or hemostasis valve, of the device was screwed on tightly, and air was drawn through the y piece.The delivery system did not make patient contact.A new 8f amplatzer trevisio intravascular delivery system was chosen and the procedure completed successfully.There was no reported patient issue.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.
 
Additional Manufacturer Narrative
An event of air entering through the hemostasis valve was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The device was received for examination and no leaks or air was noted during testing upon return to abbott.The cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER TREVISIO INTRAVASCULAR DELIVERY SYSTEM
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18131332
Report Number2135147-2023-05002
Device Sequence Number15382307
Product Code DQY
UDI-Device Identifier05415067030900
UDI-Public05415067030900
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K190581
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Catalogue Number9-ATV07F45/80
Device Lot Number8749125
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/10/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/23/2023
Supplement Date Received by Manufacturer11/28/2023
Initial Report FDA Received Date11/14/2023
Supplement Report FDA Received Date12/19/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/08/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-